Efficacy and tolerability of perampanel as a first add-on therapy with different anti-seizure drugs

Author:

Santamarina Estevo,Bertol VicenteORCID,Garayoa Vanesa,García-Gomara María José,Garamendi-Ruiz Iñigo,Giner PauORCID,Aranzábal Inés,Piera Anna,Arcos Carolina,Esteve Patricia,Marinas AinhoaORCID,García-Escrivá Alejandro,Viloria-Alebesque Alejandro,Loro Fernando Ayuga,de Tienda Alejandro Ponz,Olivan José AntonioORCID,Bonet Macarena,Dávila-González Pablo,Sivera Rafael,Molins Albert,Sansa Gemma,Roche José CarlosORCID,Martínez Ana Belén,Monteagudo Sandra,Casadevall Teresa

Funder

Eisai

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology,General Medicine

Reference51 articles.

1. Overview of drugs used for epilepsy and seizures: etiology, diagnosis, and treatment;Goldenberg;P T,2010

2. Perampanel: what is its place in the management of partial onset epilepsy?;Ledingham;Neurol Ther,2013

3. Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs: a 30-Year longitudinal cohort study;Chen;JAMA Neurol,2018

4. Early identification of refractory epilepsy;Kwan;N Engl J Med,2000

5. European Medicines Agency. Fycompa (INN, perampanel): summary of product characteristics. [cited 2019 February 11]; Available from: http://www.ema.europa.eu/documents/product-information/fycompa-epar-product-information_en.pdf.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3